Carboplatin trials for Prostate cancer

All Carboplatin trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Carboplatin for Prostate cancer

• A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
  NCT07730021 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
  NCT05806515 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 133 locations
• Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
  NCT04038502 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 18 locations
• Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
  NCT05563558 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
  NCT04954599 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
  NCT06085729 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
  NCT06439225 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 14 locations
• ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
  NCT03903835 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 32 locations
• Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
  NCT05489211 · Phase: Phase 2 · Ages: 18 Years to 130 Years · Sex: All (male and female) · 96 locations
• Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
  NCT06039371 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
  NCT06632977 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 108 locations
• Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
  NCT06470243 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 174 locations

Common questions

How many trials study Carboplatin for Prostate cancer?

12 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.